CLASS II ONGOING Device recall · Reported 12 Mar 2025 · FDA Enforcement Report
Vios Monitoring System Bedside Monitor recalled by Murata Vios
Murata Vios is recalling Vios Monitoring System Bedside Monitor, distributed nationwide in the US. The recall was initiated on 9 Aug 2024 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-1292-2025
- FDA event ID
- 96252
- Recalling firm
- Murata Vios, Woodbury, MN
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 9 Aug 2024
- FDA classified
- 6 Mar 2025
- Reported
- 12 Mar 2025
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Other Reasons
- Device type
- Patient Monitors
Timeline
| 9 Aug 2024 | Recall initiated by company | |
| 6 Mar 2025 | Classified by FDA | +209 days |
| 12 Mar 2025 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Batteries may deplete over time while not in use if devices are stored without being plugged in to wall outlet. Depleted batteries may lead to tablet connectivity issues.
Product as listed by the FDA
Vios Monitoring System Bedside Monitor Model BSM2050
Where it was distributed
US Nationwide distribution in the states of Florida, Louisiana, Maryland, Montana, New York, Ohio, and Texas.
Questions about this recall
Why was it recalled?
Batteries may deplete over time while not in use if devices are stored without being plugged in to wall outlet. Depleted batteries may lead to tablet connectivity issues.
Which lots are affected?
1.56.01 UDI: +B595BSM20500/$$7V1.56.01/16D20230630S 1.57.20 UDI: +B595BSM20500/$$7V1.57.20/16D20231129Y Software Versions 1.56.01 and 1.57.20
Where was it sold?
US Nationwide distribution in the states of Florida, Louisiana, Maryland, Montana, New York, Ohio, and Texas.
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Murata Vios
All 4| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Vios Monitoring System Bedside Monitor recalled by Murata Vios | Murata Vios | Device Malfunction | Nationwide |
| Device | CLASS II | Monitoring System recalled by Murata Vios | Murata Vios | Device Malfunction | Nationwide |
| Device | CLASS II | Monitoring System recalled by Murata Vios | Murata Vios | Device Malfunction | Nationwide |
Other Patient Monitors recalls
All 1,023| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Embletta MPR PG Multi Parameter Recorder Sleep Monitor recalled | Natus Medical | Other | Nationwide |
| Device | CLASS III | Passport Series Patient Monitor recalled by Mindray DS USA | Mindray DS USA | Device Malfunction | Nationwide |
| Device | CLASS III | T1 Patient Monitor recalled by Mindray DS USA | Mindray DS USA | Device Malfunction | Nationwide |
| Device | CLASS III | cPM Series Patient Monitor recalled by Mindray DS USA | Mindray DS USA | Device Malfunction | Nationwide |
| Device | CLASS III | BeneVision Series Telemetry Monitor recalled by Mindray DS USA | Mindray DS USA | Device Malfunction | Nationwide |